ARTEMISMED · NSE
Artemis Medicare Services Limited
₹340.8
+0.47% (+₹1.6)
Prev. close
₹339.2
Volume
98,694
Delivery %
50.5%
As of
20 Nov 2026
Price history
Analyst sentiment
No analyst stances in this range
0 analyst stances · last 90 days · one per analyst
Try a wider range.
Explore by date range →Analyst opinions
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Bullish on Artemis Medicare, recommending a buy at Rs 307–317 for a target of Rs 358, with a stop loss at Rs 284. The st…” | Dharmesh ShahICICI Securities | Artemis Medicare | HIT |
Fundamentals
About Artemis Medicare Services Limited
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, mix of inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Details
CEO
Dr. Devlina Chakravarty DMRD, DNB, M.D., Radiology
Headquarters
Gurugram
Employees
2,055
Website
artemishospitals.comExchange
View on NSE ↗Key stats
P/E ratio (TTM)
131.1
EPS (TTM)
₹2.29
Beta (1Y · daily vs NIFTY 50)
0.82
Beta (5Y · monthly vs NIFTY 50)
2.03
Shares float
3.23 Cr
Financial Performance
01 · Financials
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
Revenue | ₹402.06 Cr | ₹544.78 Cr | ₹714.33 Cr | ₹845.23 Cr | ₹913.26 Cr | ₹1,060.49 Cr |
EBITDA | ₹41.83 Cr | ₹71.06 Cr | ₹100.92 Cr | ₹135.66 Cr | ₹182.76 Cr | ₹211.96 Cr |
Net income | ₹6.00 Cr | ₹32.58 Cr | ₹39.69 Cr | ₹49.15 Cr | ₹83.46 Cr | ₹103.44 Cr |
Diluted EPS | ₹0.49 | ₹2.34 | ₹2.86 | ₹3.53 | ₹5.36 | ₹6.55 |
Net income for Mar 2021 could not be checked against the company's own annual report: this page shows ₹6.00 Cr while the annual report gives ₹7.09 Cr (18.1% apart).
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
Total assets | ₹600.00 Cr | ₹710.00 Cr | ₹905.00 Cr | ₹972.00 Cr | ₹1,357.00 Cr | ₹1,429.00 Cr |
Stockholders' equity | ₹320.00 Cr | ₹359.00 Cr | ₹403.00 Cr | ₹449.00 Cr | ₹838.00 Cr | ₹935.00 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
Capital expenditure | ₹34.00 Cr | ₹109.00 Cr | ₹146.00 Cr | ₹73.00 Cr | ₹93.00 Cr | ₹105.00 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21–Mar 22(3Q) | Jun 22 | Sep 22 | Dec 22–Mar 23(2Q) | Jun 23–Mar 24(4Q) | Jun 24 | Sep 24–Mar 25(3Q) | Jun 25–Sep 25(2Q) | Nov 25 | Dec 25–Jun 26(3Q) |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.82% | 69.59% | 69.27% | 68.92% | 68.03% | 67.51% | 67.17% | 66.53% | 58.43% | 58.39% |
| Public | 30.18% | 30.41% | 30.73% | 31.08% | 31.97% | 32.49% | 32.83% | 33.47% | 41.57% | 41.61% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
Artemis Medicare Services (ARTEMISMED) Share Price Rises 5.33% to Rs 344.60 Today
Univest · 6 days ago